
We will promptly coordinate a doctor consultation and medical treatment in Israel.
Tel / Whatsapp / Viber +972 54 803 45 32 info@resultmed.com
!מבקרים באתר היקרים, אנא שימו לב
.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד
Precision (personalized) medicine strives to give every metastatic cancer patient whose standard treatment has failed, the most appropriate (personal) protocol based on their tumor profile.
Some oncotests are done in Israel, others – in USA.
Clinical trials for most genetic variants are performed in a laboratory of molecular genetics or molecular pathology.
They use technologies such as:
Next Generation Sequencing is an advanced technology that is used for analyzing the tumor in order to determine which genes, known to be related to cancer, play a role in the formation of the patient’s tumor. The innovative technology enables rapid and accurate scanning of a very large number of genes and is used in these tests to scan more than 300 genes in tumor cells.
This test allows to determine sequence of bases of each gene. Changes that occurred in these genes are exposed in cancer cells, called somatic mutations, that exist in the tumor cells but are not transmitted by inheritance from a parent to his child.
Lab specialists enable to identify using the tools of bioinformatics and computed databases which of the mutations found in the tumor is important for the development of the cancer. On the basis of this information they can check whether there are known drugs or treatments in clinical trials that can be used to fight the specific tumor.
Based on the tests results our doctors are able:
Many studies conducted in recent years have shown a higher survival rate in patients. These who received targeted treatment than in those who did not have genetic changes or were not treated according to the tumor’s unique genetics. When patients received targeted treatment adjusted for genetic changes identified by molecular genetic (genomic) tests, patient survival, response to treatment, and disease stability were significantly better.
In a study conducted in triple negative breast cancer patients, it was found that in patients who received targeted treatment adapted to the genetic changes determined in molecular (genomic) tests, the progression of the disease was slower than those treated for genomic changes or patients without genomic changes.
Due to molecular genomic tests, Israeli oncologists have adapted the treatment personally to the particular patient – according to the tumor origin and according to the patient’s personal needs. But today, the term precision (personalized) medicine in oncology refers to how the genetic characteristics of the tumor dictate the type of treatment given. A comprehensive and accurate genome diagnostics of the new generation enables physicians to provide focused treatment based on the specific genetic characteristics of the particular tumor.
!מבקרים באתר היקרים, אנא שימו לב
.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד